What we owe to alpha(1)-antitrypsin and to Carl-Bertil Laurell.
about
In vivo bone formation by progeny of human embryonic stem cells.The parallel lives of alpha1-antitrypsin deficiency and pulmonary alveolar proteinosis.Alpha-1 antitrypsin (AAT) deficiency - what are the treatment options?Editorial: the Journal of COPD--new directions in disease understanding and management.Estimating the risk for alpha-1 antitrypsin deficiency among COPD patients: evidence supporting targeted screening.Deficiência de alfa-1 antitripsina: diagnóstico e tratamento
P2860
What we owe to alpha(1)-antitrypsin and to Carl-Bertil Laurell.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
2004年论文
@zh
2004年论文
@zh-cn
name
What we owe to alpha(1)-antitrypsin and to Carl-Bertil Laurell.
@ast
What we owe to alpha(1)-antitrypsin and to Carl-Bertil Laurell.
@en
type
label
What we owe to alpha(1)-antitrypsin and to Carl-Bertil Laurell.
@ast
What we owe to alpha(1)-antitrypsin and to Carl-Bertil Laurell.
@en
prefLabel
What we owe to alpha(1)-antitrypsin and to Carl-Bertil Laurell.
@ast
What we owe to alpha(1)-antitrypsin and to Carl-Bertil Laurell.
@en
P2860
P356
P1476
What we owe to alpha(1)-antitrypsin and to Carl-Bertil Laurell.
@en
P2093
Robin W Carrell
P2860
P356
10.1081/COPD-120028703
P407
P577
2004-04-01T00:00:00Z